Onconetix on Thursday said it named its interim Chief Financial Officer, Karina Fedasz, as interim Chief Executive Officer, effective immediately. Also on Thursday, the biotechnology company said ...

CINCINNATI, March 24, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc., (Nasdaq: ONCO) ("Onconetix" or the “Company”), (formerly Blue Water Biotech, Inc. (BWV)), a cancer ...

The company states: “Onconetix (ONCO) announced that new clinical data of Proclarix was presented on March 23, 2025 during the 2025 European Association of Urology congress, which data further ...

Portage Biotech Inc., a clinical stage immune-oncology company, engages in the research and develops pharmaceutical and biotechnology products. Its product pipeline comprises PORT-8, a dual ...

Liquidia Corporation announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) resubmission for YUTREPIA™ (treprostinil) inhalation powder to treat ...

At close: 24 March at 4:00:00 pm GMT-4 ...

BCLI Brainstorm Cell Therapeutics Inc.